Advertisement

Fish Oil and Occlusive Vascular Disease

  • M. Goerig
  • A. Habenicht
  • G. Schettler
Conference paper
Part of the Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften book series (HD AKAD, volume 1988 / 1988/4)

Summary

Fish oils and ω-3 polyunsaturated fatty acids exhibit hypolipidemic effects and both antiaggregatory and antiinflammatory properties (Table 1), they may lead to complex and only partially understood alterations of cellular interactions. The available data raise the question of the potential therapeutic and preventive value of dietary supplementation with ω-3 polyunsaturated fatty acids in occlusive vascular diseases.

Keywords

Polyunsaturated Fatty Acid Docosahexaenoic Acid Eicosapentaenoic Acid Fish Consumption Occlusive Vascular Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahmed AA, Holub BJ (1984) Alterations and recovery of bleeding times, platelet aggregation, and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod liver oil. Lipids 19:617 – 624PubMedCrossRefGoogle Scholar
  2. 2.
    Ahrens EH, Insull W, Hirsch J (1959) The effect on human serum lipids of dietary fat, highly unsaturated but poor in essential fatty acids. Lancet 1: 115 – 119PubMedCrossRefGoogle Scholar
  3. 3.
    Atkinson PM, Wheeler MC, Mendelsohn D, Pienaar N, Chetty N (1987) Effects of a 4-week freshwater fish (trout) diet on platelet aggregation, platelet fatty acids, serum lipids, and coagulation factors. Am J Hematol 24:143 –149PubMedCrossRefGoogle Scholar
  4. 4.
    Aveldano MI, Sprecher H (1983) Synthesis of hydroxy fatty acids from 4,7,10,13,16,19-/1-14C) docosahexaenoic acid by human platelets. J Bioi Chern 258:9339 – 9343Google Scholar
  5. 5.
    Bang HO, Dyerberg J (1972) Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 192:85 – 94PubMedCrossRefGoogle Scholar
  6. 6.
    Bang HO, Dyerberg J, Hjorne N (1976) The composition of food consumed by Greenland Eskimos. Acta Med Scand 200:69 – 73PubMedCrossRefGoogle Scholar
  7. 7.
    Bang HO, Dyerberg J, Sinclair HM (1980) The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33:2657 – 2661PubMedGoogle Scholar
  8. 8.
    Bang HO, Dyerberg J (1980) The bleeding tendency in Greenland Eskimos. Dan Med Bull 27:202 – 205PubMedGoogle Scholar
  9. 9.
    Bang HO, Dyerberg J (1980) The lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv Nutr Res 3:1–8CrossRefGoogle Scholar
  10. 10.
    Barcelli U, Glas-Greenwalt P, Pollak VE (1985) Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res 39:307–312PubMedCrossRefGoogle Scholar
  11. 11.
    Bednar M, Smith B, Pinto A, Mullane KM (1985) Neutrophil depletion suppresses Inlabeled platelet accumulation in infarcted myocardium. J Cardiovasc Pharmacol 7:906–912PubMedCrossRefGoogle Scholar
  12. 12.
    Berliner S, Sclarovski S, Lavie G, Pinkhas J, Aronson M, Agmon J (1986) The leukergy test in patients with ischemic heart disease. Am Heart J 111: 19 - 22PubMedCrossRefGoogle Scholar
  13. 13.
    Black KL, Culp B, Madison D, Randell OS, Lands WEM (1979) The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins Med 3:257 – 268PubMedCrossRefGoogle Scholar
  14. 14.
    Boustani SEI, Colette C, Monnier L, Descomps B, Crastes de Paulet A, Mendy F (1987) Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 22:711 – 714PubMedCrossRefGoogle Scholar
  15. 15.
    Bradlow BA, Chetty N, Van der Westhuyzen J, Mendelsohn D, Gibson JE (1983) The effects of a mixed fish diet on platelet function, fatty acids and serum lipids. Thromb Res 29:561– 568PubMedCrossRefGoogle Scholar
  16. 16.
    Bradlow BA (1986) Thrombosis and omega-3 fatty acids: Epidemiological and clinical aspects. In: Simopoulos AP, Kifer RR, Martin RE (eds) Health effects of polyunsaturated fatty acids in sea food. Academic, OrlandoGoogle Scholar
  17. 17.
    Bronsgeest-Schoute HC, van Gent CM, Luten JB, Ruiter A (1981) The effects of various intakes of omega-3 fatty acids on the blood lipid composition in healthy human subjects. Am J Clin Nutr 34:1752–1757PubMedGoogle Scholar
  18. 18.
    Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport JM (1983) Response of human skin to intradermal injection of leukotriene C4, D4, and B4. Br J Pharmacol 80:497-502PubMedCrossRefGoogle Scholar
  19. 19.
    Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE (1985) The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability, and blood viscosity in healthy volunteers. Atherosclerosis 55:267 – 281PubMedCrossRefGoogle Scholar
  20. 20.
    Corey EJ, Shih C, Cashman JR (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 80:3581-3584PubMedCrossRefGoogle Scholar
  21. 21.
    Croset M, Lagarde M (1986) In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets - effect on aggregation. Thromb Hemost 56:57 – 62Google Scholar
  22. 22.
    Culp BR, Lands WEM, Lucchesi BR, Pitt B, Romson J (1980) The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins 20:1021–1029PubMedCrossRefGoogle Scholar
  23. 23.
    Davidson MH, Liebson PR (1986) Marine lipids and atherosclerosis: a review. Cardiovasc Rev Rep 7:461 – 471Google Scholar
  24. 24.
    Demke DM, Peters GR, Linet OI, Metzler CM, Klott KA (1987) The effects of fish oil concentrate, Maxepa, in patients with hypercholesterinemia. 2nd Cardiovascular pharmacotherapy international symposium, Oct 18-22, San FranciscoGoogle Scholar
  25. 25.
    Dyerberg J, Bang HO, Stoffersen G, Moncada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 2:117-119PubMedCrossRefGoogle Scholar
  26. 26.
    Dyerberg J (1986) Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 44:125-134PubMedCrossRefGoogle Scholar
  27. 27.
    DiMinno G, Silver MG, Murphy S (1983) Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood 61 :1081-1085Google Scholar
  28. 28.
    Field CJ, Angel A, Clandinin MT (1985) Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr 42:1206-1220PubMedGoogle Scholar
  29. 29.
    Fischer S, Weber PC (1984) Prostaglanin 13 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 307:165-168PubMedCrossRefGoogle Scholar
  30. 30.
    Fischer S, von Schacky C, Siess W, Strasser T, Weber PC (1984) Uptake, release, and metabolism of docosahexaenoic acid in human platelets and neutrophils. Biochem Biophys Res Commun 120:907-918PubMedCrossRefGoogle Scholar
  31. 31.
    Fischer S, Weber PC, Dyerberg J (1986) The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins 32:235-2411PubMedCrossRefGoogle Scholar
  32. 32.
    Fischer S, Vischer A, Praec-Mursic, Weber PC (1987) Dietary docosahexaenoic acid is retroconverted in man to eicosapentaenoic acid, which can be quickly transformed to prostaglandin 13. Prostaglandins 34:367-375PubMedCrossRefGoogle Scholar
  33. 33.
    Fisher M, Upchurch KS, Levine PH, Johnson MH, Vaudreuil CH, Natale A, Hoogasian JJ (1986) Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 10:387-392PubMedCrossRefGoogle Scholar
  34. 34.
    Forman M, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R (1985) Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 313:1138-1141PubMedCrossRefGoogle Scholar
  35. 35.
    Galloway JH, Cartwright IJ, Woodcock BE, Greaves M, Russell GG, Preston FE (1985) Effects of dietary fish oil supplementation of the fatty acid composition on the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools. Clin Sci 68:449-454PubMedGoogle Scholar
  36. 36.
    Glomset JA (1985) Fish, fatty acids, and human health. N Engl J Med 312:1253 –1254PubMedCrossRefGoogle Scholar
  37. 37.
    Goerig M, Habenicht AJR, Schettler G (1985) Eicosanoide und Phospholipasen. Klin Wochenschrift 63:293 – 311CrossRefGoogle Scholar
  38. 38.
    Goerig M, Habenicht AJR, Heitz R, Zeh W, Katus H, Kommerell B, Ziegler R, Glomset JA (1987) Sn-1,2-diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human pro myelocytic leukemia cells. J Clin Invest 79:903-911PubMedCrossRefGoogle Scholar
  39. 39.
    Goldberg AC, Schonfeld G (1985) Effects of diet on lipoprotein metabolism. Ann Rev Nutr 5:195–212CrossRefGoogle Scholar
  40. 40.
    Goodnight SH, Harris WS, Connor WE (1981) The effects of dietary omega-3 fatty acids on platelet composition and function in man. Blood: 58:880-885PubMedGoogle Scholar
  41. 41.
    Goodnight SH, Harris WS, Connor WE, Illingworth DR (1982) Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 2: 87-113PubMedCrossRefGoogle Scholar
  42. 42.
    Grundy SM (1986) Cholesterol and coronary heart disease. A new era. JAMA 256: 2849-2858CrossRefGoogle Scholar
  43. 43.
    Habenicht AJR, Goerig M, Schettler G (1984) Neue Aspekte der Biochemie und Biologie der Arterienwand. Klin Wochenschrift 62:241-253CrossRefGoogle Scholar
  44. 44.
    Habenicht AJR, Glomset JA, Goerig M, Gronwald R, Grulich J, Loth U, Schettler G (1985) Cell cycle-dependent changes in arachidonic acid and glycerol metabolism in Swiss 3T3 cells stimulated by platelet-derived growth factor. J BioI Chern 260:1370-1373Google Scholar
  45. 45.
    Habenicht AJR, Goerig M, Grulich J, Rothe D, Gronwald R, Loth U, Schettler G, Kommerell B, Ross R (1985) Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J Clin Invest 75:1381-1387PubMedCrossRefGoogle Scholar
  46. 46.
    Habenicht AJR, Dresel HA, Goerig M, Wever J, Stoehr M, Glomset JA, Ross R, Schettler G (1986) Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA 83:1344-1348PubMedCrossRefGoogle Scholar
  47. 47.
    Hadjiagapiou C, Kaduce TL, Spector AA (1986) Eicosapentaenoic acid utilization by bovine aortic endothelial cells: effects on prostacyclin production. Biochim Biophys Acta 875 :369 – 381CrossRefGoogle Scholar
  48. 48.
    Harlan JM (1985) Leukocyte-endothelial interactions. Blood 65:513-525PubMedGoogle Scholar
  49. 49.
    Harris WS, Connor WE (1980) The effects of salmon oil upon plasma lipids, lipoproteins, and triglyceride clearance. Trans Assoc Am Physicians 43:148-155Google Scholar
  50. 50.
    Hay CRM, Durber AP, Saynor R (1982) Effect of fish oil on platelet kinetics in patients with ischaemic heart disease. Lancet 1: 1269-1272PubMedCrossRefGoogle Scholar
  51. 51.
    Hepburn FN, Exler J, Weihrauch JL (1986) Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. J Am Diet Assoc 86:788–793PubMedGoogle Scholar
  52. 52.
    Hirai A, Hamazaki T, Terano T (1980) Eicosapentaenoic acid and platelet function in Japanese. Lancet 2:1132-1133PubMedCrossRefGoogle Scholar
  53. 53.
    Illingworth DR, Harris WS, Connor WE (1984) Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis 4:270-275PubMedCrossRefGoogle Scholar
  54. 54.
    Jackson RL, Gotto AM (1976) Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. In: Paoletti R, Gotto AM Jr (eds) Atherosclerosis reviews, vol 1. Raven, New York, pp 1-21Google Scholar
  55. 55.
    Kagawa Y, Nishizawa M, Suzuki M (1982) Eicosapolyenoic acid of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol 28:441-453PubMedCrossRefGoogle Scholar
  56. 56.
    Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S (1986) Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 35:604-611PubMedCrossRefGoogle Scholar
  57. 57.
    Keys A (1980) Seven countries: a multivariate analysis of death and coronary heart disease. Harvard University Press, CambridgeGoogle Scholar
  58. 58.
    King ME, Stavens BW, Spector AA (1977) Diet-induced changes in plasma membrane fatty acid composition affect physical properties detected with a spin-label probe. Biochemistry 16:5280-5285PubMedCrossRefGoogle Scholar
  59. 59.
    Knapp HR, Reilly IAG, Allessandrini P, Fitzgerald GA (1986) In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 314:937-942PubMedCrossRefGoogle Scholar
  60. 60.
    Kromhout D, Bosschieter EB, de Lezenne-Coulander C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205-1209PubMedCrossRefGoogle Scholar
  61. 61.
    Kukreja RC, Kontos HA, Hess ML, Ellis EF (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59:612-619PubMedCrossRefGoogle Scholar
  62. 62.
    Lands WEM, Culp BR, Hirai A, Gorman R (1985) Relationship of thromboxane generation to the aggregation of platelets from humans. Effects of eicosapentaenoic acid. Prostaglandins 30:819 – 825PubMedCrossRefGoogle Scholar
  63. 63.
    Leach CM, Thorburn GD (1982) A comparative study of collagen induced thromboxane release from platelets of different species: implications for human atherosclerosis models. Prostaglandins 24:47-59PubMedCrossRefGoogle Scholar
  64. 64.
    Lee KT, Jarmolych J, Kim DN (1971) Production of advanced coronary atherosclerosis, myocardial infarction, and sudden death in swine. Exp Mol Pathol 15:170–190PubMedCrossRefGoogle Scholar
  65. 65.
    Lee TH, Menica-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF (1984) Characterisation and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J BioI Chern 259:2383-2389Google Scholar
  66. 66.
    Lee TH, Menica-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF (1984) Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74:1922-1933PubMedCrossRefGoogle Scholar
  67. 67.
    Lee TE, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217-1224PubMedCrossRefGoogle Scholar
  68. 68.
    Logan RL, Thomson M, Riemersma RA (1978) Risk factors for ischemic heart disease in normal men aged 40. Lancet i:949 – 955CrossRefGoogle Scholar
  69. 69.
    Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC (1983) Platelet function, thromboxane formation, and blood pressure control during supplementation of the western diet with cod liver oil. Circulation 67:504– 511PubMedCrossRefGoogle Scholar
  70. 70.
    von Lossonczy TO, Ruiter A, Bronsgeest-Schoute HC, van Gent CM, Hermus RJJ (1978 ) The effect of a fish oil diet on serum lipids in healthy human subjects. Am J Clin Nutr 31:1340–1346Google Scholar
  71. 71.
    Majerus PW (1983) Arachidonate metabolism in vascular disorders. J Clin Invest 72:1521-1525PubMedCrossRefGoogle Scholar
  72. 72.
    Mehta J (1983) Platelets and prostaglandins in coronary heart disease. Rationale for use of platelet-suppressive drugs. JAMA 249:2818-2823Google Scholar
  73. 73.
    Mehta P, Mehta J, Lawson D, Krop I, Letts LG (1986) Leukotrienes potentiale the effects of epinephrine and thrombin on human platelet aggregation. Thromb Res 41:731-738PubMedCrossRefGoogle Scholar
  74. 74.
    Mehta J, Lopez LM, Wargovich T (1987) Eicosapentaenoic acid: Its relevance in atherosclerosis and coronary artery disease. Am 1 Cardiol 59:155-159CrossRefGoogle Scholar
  75. 75.
    Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T (1982) Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J 285:993-996CrossRefGoogle Scholar
  76. 76.
    Moncada S, Salmon JA (1986) Leukotrienes and tissue injury: The use of eicosapentaenoic acid in the control of white cell activation. Wiener Klin Wochenschrift 98:104-106Google Scholar
  77. 77.
    Mori TA, Codde JP, Vandongen R, Beilin LJ (1987) New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation. Lipids 22:744-750PubMedCrossRefGoogle Scholar
  78. 78.
    Mullane KM, Read N, Salmon JA, Moncada S (1984) Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by antiinflammatory drugs. J Pharmacol Exp Ther 228:510-522PubMedGoogle Scholar
  79. 79.
    Murota S, Morita I (1985) Possible mechanisms of antithrombotic effect of eicosapentaenoic acid: Species specificity. Adv Prostagl Thrombox Leukot Res 15:257-259Google Scholar
  80. 80.
    Nathaniel DJ, Evans JF, Leblanc Y, Leveille C, Fitzsimmons BJ, Ford-Hutchinson AW (1985) Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil L T A4 hydrolase. Biochem Biophys Res Comm 131: 827-835PubMedCrossRefGoogle Scholar
  81. 81.
    Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H (1979) Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 76:944 – 948PubMedCrossRefGoogle Scholar
  82. 82.
    Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonate acid metabolism. Ann Rev Biochem 55:69 – 102PubMedCrossRefGoogle Scholar
  83. 83.
    Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R (1984) Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74:82 – 89PubMedCrossRefGoogle Scholar
  84. 84.
    Nestel PJ (1986) Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol. Am J Clin Nutr 43:752 –757PubMedGoogle Scholar
  85. 85.
    Nestel PJ (1987) Polyunsaturated fatty acids. Am J Clin Nutr 45:1161–1167PubMedGoogle Scholar
  86. 86.
    Niewiarowski S, Rao AK (1983) Contribution of thrombogenic factors to the pathogenesis of atherosclerosis. Prog Cardiovasc Dis 26: 197 – 222PubMedCrossRefGoogle Scholar
  87. 87.
    Ochi K, Yoshimoto T, Yamamoto S, Taniguchi K, Miyamoto T (1983) Arachidonate-5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes: activation by adenosine 5’-triphosphate. J BioI Chern 258:5754 – 5758Google Scholar
  88. 88.
    Okegawa T, Jonas PE, DeSchryver K, Kawasaki A, Needleman P (1983) Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. J Clin Invest 71 :81– 90PubMedCrossRefGoogle Scholar
  89. 89.
    Phillipson BR, Rothrock DW, Connor WE, Harris WS, Illingsworth DR (1985) Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312:1201–1216CrossRefGoogle Scholar
  90. 90.
    Prescott SM (1984) The effect ofeicosapentaenoic acid on the leukotriene B production by human neutrophils. J BioI Chern 259:7615 – 7621Google Scholar
  91. 91.
    Prescott SM, Zimmermann GA, Morrison AR (1985) The effects of a diet rich in fish oil on human neutrophils: Identification of leukotriene B5 as a metabolite. Prostaglandins 30:209 – 227PubMedCrossRefGoogle Scholar
  92. 92.
    Rao GHR, Radda E, White JG (1983) Effect of docosahexaenoic acid on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun 117: 549–555PubMedCrossRefGoogle Scholar
  93. 93.
    Riemersma RA, Wood DA, Butler EA (1986) Linoleic acid in adipose tissue and coronary heart disease. Br Med J 292:1423 –1427CrossRefGoogle Scholar
  94. 94.
    Rifkind BM (1986) Diet, plasma cholesterol, and coronary heart disease. J Nutr 116:1578 –1580PubMedGoogle Scholar
  95. 95.
    Romson JL, Hook BG, Kunkel SL, Abrams JD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016–1023PubMedCrossRefGoogle Scholar
  96. 96.
    Ross R (1986) The pathogenesis of arteriosclerosis - an update. N Engl J Med 314:488 – 500Google Scholar
  97. 97.
    Sanders TAB, Naismith DJ, Haines AP, Vickers M (1980) Cod liver oil, platelet fatty acids, and bleeding time. Lancet 1: 1189PubMedCrossRefGoogle Scholar
  98. 98.
    Sanders TB, Vickers M, Haines AP (1981) Effect on blood lipids and hemostasis of a supplement of cod liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin Sci 61:317–324PubMedGoogle Scholar
  99. 99.
    Sanders TAB, Younger KM (1981) The effect of dietary supplements of omega-3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglycerides. Br J Nutr 45:613 – 616PubMedCrossRefGoogle Scholar
  100. 100.
    Sanders TAB (1987) Fish and coronary artery disease. Br Heart J 57:214–219PubMedCrossRefGoogle Scholar
  101. 101.
    Saynor R, Verel D, Gillott T (1984) The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets, and angina. Atherosclerosis 50: 3 – 10PubMedCrossRefGoogle Scholar
  102. 102.
    von Schacky C, Fischer S, Weber PC (1985) Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 76:1626–1631CrossRefGoogle Scholar
  103. 103.
    von Schacky C, Weber PC (1985) Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 76:2446 – 2450CrossRefGoogle Scholar
  104. 104.
    von Schacky C, Siess W, Fischer S, Weber PC (1985) A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res 26:457–464Google Scholar
  105. 105.
    Shea MJ, Driscoll RM, Romson JL, Bitt B, Lucchesi BR (1984) The beneficial effect of nafazatrom on experimental coronary thrombosis. Am Heart J 107 :629 – 637PubMedCrossRefGoogle Scholar
  106. 106.
    Schettler G (1986) Relevance of fatty acids and eicosanoids to clinical and preventive medicine. Prog Lipid Res 25:1–4PubMedCrossRefGoogle Scholar
  107. 107.
    Schettler G (ed) (1987) Molecular biology of the arterial wall. Springer, Berlin Heidelberg New YorkGoogle Scholar
  108. 108.
    Shekelle RB, Missell L, Paul O, Shyrock A, Stammler J (1985) Fish consumption and mortality from coronary heart disease. N Engl J Med 313:820CrossRefGoogle Scholar
  109. 109.
    Siess W, Scherer B, Bohling B, Roth P, Kurzmann I, Weber PC (1980) Platelet membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet i:441– 444CrossRefGoogle Scholar
  110. 110.
    Simpson HCR, Barker K, Carter RD, Cassels E, Mann JI (1982) Low dietary intake of linoleic acid predisposes to myocardial infarction. Br Med J 285:683 – 684CrossRefGoogle Scholar
  111. 111.
    Sinclair H, Gale M (1987) Eicosapentaenoic acid in fat. Lancet i:1202CrossRefGoogle Scholar
  112. 112.
    Soter NA, Lewis RA, Corey EJ, Austen KF (1983) Local effects of synthetic leukotrienes in human skin. J Invest Dermatol 80: 115 – 119PubMedCrossRefGoogle Scholar
  113. 113.
    Strasser T, Fischer S, Weber PC (1985) Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid. Proc Natl Acad Sci USA 82:1540–1543PubMedCrossRefGoogle Scholar
  114. 114.
    Stubbs CD, Smith AD (1984) The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779:89 –137PubMedCrossRefGoogle Scholar
  115. 115.
    Tamura Y, Hirai A, Terano T, Kumagai A, Yoshida S (1985) Effects of eicosapentaenoic acid on hemostatic function and serum lipids in humans. Adv Prostagl Thrombox Leukot Res 15:265 – 267Google Scholar
  116. 116.
    Terano T, Salmon JA, Moncada S (1984) Biosynthesis and biologic activity of leukotriene B5. Prostaglandins 27:217 – 232PubMedCrossRefGoogle Scholar
  117. 117.
    Thorngren M, Gustafson A (1981) Effects of 11-week increase in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet ii:1190–1193CrossRefGoogle Scholar
  118. 118.
    Thorogood M, Carter R, Benfield L, McPherson K, Mann JI (1987) Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J 295:351– 357CrossRefGoogle Scholar
  119. 119.
    Tripp CS, Unanue ER, Needleman P (1986) Monocyte migration explains the changes in macrophage arachidonate metabolism during the immue response. Proc Natl Acad Sci USA 83:9655 – 9659PubMedCrossRefGoogle Scholar
  120. 120.
    Tzeng DY, Deuel TF, Huang JS, Baehner RL (1985) Platelet-derived growth factor promotes human peripheral monocyte activation. Blood 66:179–183PubMedGoogle Scholar
  121. 121.
    Wargovich T, Mehta J, Nichols WW, Pepine CJ, Conti CR (1985) Reduction of blood flow in normal and narrowed coronary arteries of dogs by leukotriene C. J Am Coll Cardiol 6:1047 –1051CrossRefGoogle Scholar
  122. 122.
    Weiner BH, Ockene IS, Jarmolych J, Fritz KE, Daoud AS (1985) Comparison of phatologic and angiographic findings in a porcine preparation of coronary atherosclerosis. Circulation 72:1081–1086PubMedCrossRefGoogle Scholar
  123. 123.
    Weiner BH, Ockene IS, Levine PH, Cuenoud HF, Fisher M, Johnson BF, Daoud AS, Jarmolych J, Hosmer D, Johnson MH, Natale A, Vaudreuil C, Hoogasian JJ (1986) Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 315:841 – 846PubMedCrossRefGoogle Scholar
  124. 124.
    Weiner MA (1986) Cholesterol in foods rich in omega-3 fatty acid. N Engl J Med 315:833PubMedCrossRefGoogle Scholar
  125. 125.
    Wong SH, Nestel PJ, Trimble RP, Storer GB, Illman RJ, Topping DL (1984) The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochem. Biophys. Acta 792:103–109CrossRefGoogle Scholar
  126. 126.
    Wood DA, Butler S, Riemersma RA, Thomson M, Oliver MF (1984) Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men. Lancet ii:117 –121CrossRefGoogle Scholar
  127. 127.
    Wood DA, Riemersma RA, Butler S, Thomson M, MacIntyre C, Elton RA, Oliver MF (1987) Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet i: 177 – 183CrossRefGoogle Scholar
  128. 128.
    Woodcock BE, Smith E, Lambert WH, Jones WM, Galloway JH, Greaves M, Preston FE (1984) Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 288:592 – 594CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. Goerig
  • A. Habenicht
  • G. Schettler

There are no affiliations available

Personalised recommendations